Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Gadodiamide (liposomal)

EU orphan designation number: EU/3/08/583   
Active ingredient: Gadodiamide (liposomal)
Indication: Treatment of glioma
Sponsor: Dr. Matthias Luz
Brunhildestraße 46, D-68199 Mannheim, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
05/12/2008 Centralised Orphan - Designation EMEA/OD/034/08 (2008)8093 of 03/12/2008